BML Investment Partners, L.P. 13D and 13G filings for Whitehawk Therapeutics Inc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-05 3:58 pm Unchanged |
2025-03-05 | 13D | Whitehawk Therapeutics Inc WHWK |
BML Investment Partners, L.P. | 2,435,000 4.980% |
0 (Unchanged) |
Filing |
| 2025-02-24 11:38 am Unchanged |
2025-02-24 | 13D | Whitehawk Therapeutics Inc WHWK |
BML Investment Partners, L.P. | 2,435,000 9.900% |
0 (Unchanged) |
Filing |
| 2025-02-04 11:11 am Unchanged |
2025-02-03 | 13D | Whitehawk Therapeutics Inc WHWK |
BML Investment Partners, L.P. | 2,435,000 9.900% |
0 (Unchanged) |
Filing |
| 2025-01-30 3:32 pm Unchanged |
2025-01-30 | 13D | Whitehawk Therapeutics Inc WHWK |
BML Investment Partners, L.P. | 2,435,000 9.900% |
0 (Unchanged) |
Filing |
| 2024-12-31 11:13 am Purchase |
2024-12-31 | 13D | Whitehawk Therapeutics Inc WHWK |
BML Investment Partners, L.P. | 2,435,000 9.900% |
1,051,183 (+75.96%) |
Filing |
| 2024-08-28 4:42 pm Purchase |
2024-08-28 | 13G | Whitehawk Therapeutics Inc WHWK |
BML Investment Partners, L.P. | 1,383,817 5.600% |
1,383,817 (New Position) |
Filing |